glp 1 pathophysiology Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism Unlocking the multifaceted roles of

(December 2025)

Effects of liraglutide on depressive behavior in a mouse depression model and cognition in the probe trial of Morris water maze test

Researchers emphasised the promising neurobehavioural and metabolic effects of GLP-1RAs, particularly exenatide and semaglutide, in smoking cessation

The lack of clarity makes choosing a company potentially confusing for patients, and the medical profession is partly to blame, said Jamy Ard, an obesity doctor and researcher at Wake Forest University School of Medicine in Winston-Salem, North Carolina

doi:10.1177/10600280251407145

Orforgliprons approval highlights both the growing role of GLP-1 therapies in weight loss and the potential for faster regulatory pathways, bringing new treatments to patients sooner